Good MorningThe S&P 500 held steady on Tuesday. The market is awaiting today’s expected tariff announcement and appears poised to move once the news breaks. The question is whether the tariffs are as bad as the market feared or worse. If only as bad as feared, there is a chance the index could begin to rebound on the news. As it is, the S&P 500 is down about 10% from its peaks.
Labor market data is the other market-moving news this week. The data is expected to show resilient conditions that otherwise suggest economic health. The risk for the market is twofold. If the data is hot, it will raise fears of inflation, high interest rates, and a potential recession, while weak data will point to a recession.
The narrative may begin to change as soon as next week. The first significant earnings reports of the Q1 reporting cycle are due and will set the tone for the season. Featured: He started with $2,000. Now he's at $3 million. (Ad) 
|
Technology | |
Salesforce (NYSE: CRM) is among the most resilient software stocks for reductions in business spending and the market downturns they cause, at least in the eyes of analysts at Evercore ISI. They believe the company’s AI offering and breadth set it apart from competitors, and that moat is r... Read the Full Story |
|
From Our Partners | | A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years.
While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million.
One company controls the entire supply chain behind this discovery. | | See the ticker behind this Grand Canyon energy breakthrough now |
|
Markets | |
The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) is trading down 5.19%, and the NASDAQ 100, as tracked by the Invesco QQQ (NASDAQ: QQQ), is down 8.2% year-to-date (YTD) as of March 28, 2025. The markets attempted a relief rally that was rejected at the 200-day moving average on the SPY. A number o... Read the Full Story |
|
Technology | |
Investors may see a disconnect between the headlines that D-Wave Quantum Inc. (NYSE: QBTS) has generated and its share price performance in recent weeks. The quantum computing firm came out with two seemingly significant technological updates so far in 2025—first, a report that it had achiev... Read the Full Story |
|
From Our Partners | | Palantir, Micron and SanDisk show how fast a stock can become the trade everyone suddenly wants. That's often when investors make their costliest mistake: arriving after the easy part of the move is gone.
A new premium eBook flags 7 stocks that may be worth knowing about before the broader crowd catches on. You don't need to buy any of them - just knowing what's quietly gaining attention can be useful. | | See the 7 stocks on the watchlist while it's still free |
|
Consumer Discretionary | |
Amazon.com Inc. (NASDAQ: AMZN) is back in the spotlight after falling to fresh 2025 lows during Monday's session. The stock, now down more than 20% from its all-time high in February, is officially in a technical bear market. This latest drop is particularly notable because it has brought shares... Read the Full Story |
|
Energy | |
Occidental Petroleum Co. (NYSE: OXY) stock and Warrant Buffett are often used in the same sentence these days. Even as Warren Buffett has raised his cash holdings in Berkshire Hathaway Inc. (NYSE: BRK.A) (NYSE: BRK.B), Occidental was one of the few stocks he has upped his stakes in.
As Occident... Read the Full Story |
|
From Our Partners | | AI is expanding beyond software into robots, factories, vehicles, and intelligent machines. That shift could create a new group of market leaders before most investors notice.
A complimentary report, 5 Stocks Powering the Physical AI Revolution, identifies five companies positioned at the center of this shift, along with the technologies, growth drivers, and risks to understand. | | Get your free copy before physical AI becomes Wall Street's next crowded trade |
|
Finance | |
While the broader equity market has had a challenging start to 2025, Berkshire Hathaway Inc. (NYSE: BRK.B) shares have charted a notably different course. With most indices facing headwinds and volatility, the Omaha-based conglomerate's stock has registered healthy gains. The company’s suc... Read the Full Story |
|
Technology | |
The sell-off in technology stocks picked up steam on Mar. 31, 2025. The technology-heavy NASDAQ index continued to trend lower even as the Dow and S&P 500 made gains. As has been the case this year, blue-chip tech stocks like Microsoft Corporation Corp. (NASDAQ: MSFT) were among the targets.
... Read the Full Story |
|
Technology | |
Investors may object to the current valuation of Palantir Technologies Inc. (NASDAQ: PLTR) stock. But they can’t say that there’s no news to support bullish sentiment. The latest example of the company’s formidable growth expectations is its announcement of the extension of its... Read the Full Story |
|
Markets | |
Faster-than-average global energy demand growth in 2024 has helped to contribute to rising interest in nuclear energy, renewables, and natural gas so far in 2025. The U.S. Energy Information Administration (EIA) expects these trends to continue and has singled out natural gas as a particular energ... Read the Full Story |
|
Healthcare | |
When Wall Street analysts decide to come out of their caves and boost a certain stock, retail investors should pay attention to the motives behind the decision as it can signal a shift in sentiment toward an entire sector.
That’s exactly what happened when J.P. Morgan recently upgraded Gile... Read the Full Story |
|
Wednesday's Early Bird Stock Of The Day Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California. | | View Today's Stock Pick |
|
